Background and Purpose Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of oral glucose-lowering drugs used in the treatment type 2 diabetes. In pilot study using human kidney biopsies, we observed high DPP-4 expression early crescent formation. This glomerular lesion occurs different diseases is hallmark pathogenesis renal dysfunction. Therefore, investigated potential involvement nephrit...